Related references
Note: Only part of the references are listed.Putative Tumor Suppressor miR-145 Inhibits Colon Cancer Cell Growth by Targeting Oncogene Friend Leukemia Virus Integration 1 Gene
Jianjun Zhang et al.
CANCER (2011)
MiR-145 inhibits cell proliferation of human lung adenocarcinoma by targeting EGFR and NUDT1
William C. S. Cho et al.
RNA BIOLOGY (2011)
miR-145 and miR-133a function as tumour suppressors and directly regulate FSCN1 expression in bladder cancer
T. Chiyomaru et al.
BRITISH JOURNAL OF CANCER (2010)
MicroRNA-145 Suppresses Cell Invasion and Metastasis by Directly Targeting Mucin 1
Mohit Sachdeva et al.
CANCER RESEARCH (2010)
miR-145 participates with TP53 in a death-promoting regulatory loop and targets estrogen receptor-α in human breast cancer cells
R. Spizzo et al.
CELL DEATH AND DIFFERENTIATION (2010)
miRNA-145 inhibits non-small cell lung cancer cell proliferation by targeting c-Myc
Zhe Chen et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2010)
MiR-145, a new regulator of the DNA Fragmentation Factor-45 (DFF45)-mediated apoptotic network
Jianjun Zhang et al.
MOLECULAR CANCER (2010)
miR-145 induces caspase-dependent and -independent cell death in urothelial cancer cell lines with targeting of an expression signature present in Ta bladder tumors
M. S. Ostenfeld et al.
ONCOGENE (2010)
Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics
G. L. Semenza
ONCOGENE (2010)
The microRNA network and tumor metastasis
H. Zhang et al.
ONCOGENE (2010)
miR-145-dependent targeting of Junctional Adhesion Molecule A and modulation of fascin expression are associated with reduced breast cancer cell motility and invasiveness
M. Goette et al.
ONCOGENE (2010)
MicroRNA-145 Targets YES and STAT1 in Colon Cancer Cells
Lea H. Gregersen et al.
PLOS ONE (2010)
Characterization of global microRNA expression reveals oncogenic potential of miR-145 in metastatic colorectal cancer
Greg M. Arndt et al.
BMC CANCER (2009)
MicroRNA deregulation and pathway alterations in nasopharyngeal carcinoma
H-C Chen et al.
BRITISH JOURNAL OF CANCER (2009)
MicroRNA-145 Regulates OCT4, SOX2, and KLF4 and Represses Pluripotency in Human Embryonic Stem Cells
Na Xu et al.
CELL (2009)
Uncovering Growth-Suppressive MicroRNAs in Lung Cancer
Xi Liu et al.
CLINICAL CANCER RESEARCH (2009)
MicroRNAs miR-143 and miR-145 modulate cytoskeletal dynamics and responsiveness of smooth muscle cells to injury
Mei Xin et al.
GENES & DEVELOPMENT (2009)
Identification of novel microRNA targets based on microRNA signatures in bladder cancer
Takahiro Ichimi et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Modulation of microRNA processing by p53
Hiroshi I. Suzuki et al.
NATURE (2009)
Decreased Expression of MicroRNA-143 and -145 in Human Gastric Cancers
Takeshi Takagi et al.
ONCOLOGY (2009)
miR-145 directs intestinal maturation in zebrafish
Lei Zeng et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
p53 represses c-Myc through induction of the tumor suppressor miR-145
Mohit Sachdeva et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Discovery of microvascular miRNAs using public gene expression data: miR-145 is expressed in pericytes and is a regulator of Fli1
Erik Larsson et al.
GENOME MEDICINE (2009)
Cancer statistics, 2008
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2008)
Endothelial p70 S6 kinase 1 in regulating tumor angiogenesis
Ling-Zhi Liu et al.
CANCER RESEARCH (2008)
Translation inhibitor Pdcd4 is targeted for degradation during tumor promotion
Tobias Schmid et al.
CANCER RESEARCH (2008)
Diagnostic and prognostic microRNAs in stage II colon cancer
Troels Schepeler et al.
CANCER RESEARCH (2008)
mTOR Pathway and mTOR Inhibitors as Agents for Cancer Therapy
Paolo Baldo et al.
CURRENT CANCER DRUG TARGETS (2008)
Role of mTOR in anticancer drug resistance: Perspectives for improved drug treatment
Bing-Hua Jiang et al.
DRUG RESISTANCE UPDATES (2008)
Suppression of programmed cell death 4 (PDCD4) protein expression by BCR-ABL-regulated engagement of the mTOR/p70 S6 kinase pathway
Nathalie Carayol et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
MicroRNA signatures in human ovarian cancer
Marilena V. Iorio et al.
CANCER RESEARCH (2007)
Regulation of the p27Kip1 tumor suppressor by miR-221 and miR-222 promotes cancer cell proliferation
Carlos le Sage et al.
EMBO JOURNAL (2007)
Reactive oxygen species regulate insulin-induced VEGF and HIF-1 alpha expression through the activation of p70S6K1 in human prostate cancer cells
Qiong Zhou et al.
CARCINOGENESIS (2007)
Altered expression of miR-21, miR-31, miR-143 and miR-145 is related to clinicopathologic features of colorectal cancer
O. Slaby et al.
ONCOLOGY (2007)
Reactive oxygen species regulate epidermal growth factor-induced vascular endothelial growth factor and hypoxia-inducible factor-1α expression through activation of AKT and P70S6K1 in human ovarian cancer cells
Ling-Zhi Liu et al.
FREE RADICAL BIOLOGY AND MEDICINE (2006)
Identification by Real-time PCR of 13 mature microRNAs differentially expressed in colorectal cancer and non-tumoral tissues
E. Bandres et al.
MOLECULAR CANCER (2006)
MicroRNA gene expression deregulation in human breast cancer
MV Iorio et al.
CANCER RESEARCH (2005)
Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers
GA Calin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Vascular endothelial growth factor transcriptional activation is mediated by hypoxia-inducible factor 1α, HDM2, and p70S6K1 in response to phosphatidylinositol 3-kinase/AKT signaling
HD Skinner et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
The TOR pathway: A target for cancer therapy
MA Bjornsti et al.
NATURE REVIEWS CANCER (2004)
Micro RNAs are complementary to 3′ UTR sequence motifs that mediate negative post-transcriptional regulation
EC Lai
NATURE GENETICS (2002)
microRNAs: Tiny regulators with great potential
V Ambros
CELL (2001)
An extensive class of small RNAs in Caenorhabditis elegans
RC Lee et al.
SCIENCE (2001)